Optogenetics is an emerging technology for the manipulation and control of excitable tissues, such as the brain and heart. As this technique requires the genetic modification of cells in order to inscribe light sensitivity, for cardiac applications, here we describe the process through which neonatal rat ventricular myocytes are virally infected in vitro with channelrhodopsin-2 (ChR2). We also describe in detail the procedure for quantitatively determining the optimal viral dosage, including instructions for patterning gene expression in multicellular cardiomyocyte preparations (cardiac syncytia) to simulate potential in vivo transgene distributions. Finally, we address optical actuation of ChR2-transduced cells and means to measure their functional response to light.
Introduction
Optogenetic control of cardiomyocytes is achieved through the genetic insertion of lightsensitive ion channels and/or pumps of microbial origin (opsins) to render cells controllable by light. This technique can be used for contactless manipulation of activity in excitable tissues such as the brain and heart. In neuroscience, optogenetics has become the tool of choice to dissect neural circuits and brain connectivity in health and disease through cellspecific targeting since its first reported application in 2005 [1] . Since then, a myriad of studies have linked specific neural populations to behavior (for review see refs. [2] [3] [4] [5] and addressed their contribution to such conditions as depression [6] , anxiety [7] , addiction [8, 9] , and sleep disorders [10] . Pioneering novel optical therapies have stemmed from this technique in the treatment of diseases, such as epilepsy [11, 12] , Parkinson's [13] [14] [15] , and retinal degeneration [16] . Only more recently (since 2010) has optogenetics been applied in the heart (for review see ref. 17) . In vitro cardiac applications have thus far explored the utility of expressing channelrhodopsin-2 (ChR2), an excitatory opsin, through viral means in a mouse embryonic stem cell line followed by differentiation to cardiomyocytes [18, 19] as well as through a tandem cell unit approach where nonexcitable cells, expressing ChR2, are coupled to cardiomyocytes, thus inscribing light sensitivity to the cardiac syncytium [20] .
The microbial opsins at the core of optogenetics can produce either depolarizing (excitatory) currents or hyperpolarizing (inhibitory) currents in mammalian cells. Excitatory opsins, such as channelrhodopsin (ChR), can provide fast kinetic currents of sufficient amplitude to trigger action potentials, whereas inhibitory opsins, such as halorhodopsin (HR) and archaerhodopsin (AR) can suppress activity via fast onset of hyperpolarization [21] . When an opsin is activated by a photon of the appropriate wavelength light, the chromophore alltrans-retinal, which is covalently bound to the channel, is isomerized to 13-cis-retinal resulting in the opening of the channel. Depending on the channel, cations (ChR, AR) or anions (HR) flow with or are pumped against the electrochemical gradient across the cell membrane to change transmembrane potential. Mutant opsins are also available which are designed to improve upon light sensitivity, speed, and spectral response [22, 23] . In the case of cardiac optogenetics, the most commonly used mutant excitatory opsin is ChR2(H134R). ChR2(H134R) was one of the first single amino acid mutants generated and results in a 2-3× increase in channel conductance with minimal effect on kinetics [24] .
Optogenetics opens the possibility for an all-optical investigation of neural and cardiac electrophysiology when optical mapping (using voltage-and calcium-sensitive dyes) is combined with these new optical actuation tools. Our 2011 study was the first to combine optical stimulation with high-speed, high-resolution optical mapping [20] . The integration of these techniques allowed the quantitative comparison of wave propagation and conduction properties of both optical and electrical stimulation. As will be discussed in this chapter, care must be taken when choosing opsins and optical sensors, such as calcium-and voltagesensitive dyes, for a combined experiment, as excitation and emission spectra may overlap making data interpretation difficult.
This chapter describes the process for direct virally mediated opsin expression in cardiomyocytes, including methods for spatial gene patterning in cardiac syncytium. We specifically outline step-by-step procedures for in vitro infection of neonatal rat ventricular cardiomyocytes (NRVMs) with an adenovirus containing the transgene for ChR2(H134R) fused to an eYFP reporter protein with a ubiquitous CMV promoter. This technique is also applicable to (and has been tested in) other cardiac cell types (including adult cells) with appropriately designed optogenetic viruses and optimization of the viral infection protocol as described here.
Materials

Isolating and Preparing Cells for Adenoviral Infection
1. NRVM culture media: M199 media (Invitrogen, Grand Island, NY, USA) supplemented with 10 % fetal bovine serum (FBS), 12 μM L-glutamine, 0.02 μg/mL glucose, 0.05 μg/mL penicillin-streptomycin, and 10 mM HEPES. Store at 4 ºC. Warm to 37 ºC before use.
2.
NRVMs prepared according to Jia et al. [20] .
Determining the Optimal Multiplicity of Infection
1.
Custom-designed Ad-ChR2(H134R)-eYFP or other virus containing an appropriate light-sensitive opsin. Viral titer is 9×10 11 viral particles (VP)/mL (see Note 1).
Phosphate-buffered saline (PBS).
3. NRVM culture media: M199 media (Invitrogen, Grand Island, NY, USA) supplemented with 10 % FBS, 12 μM l-glutamine, 0.02 μg/mL glucose, 0.05 μg/mL penicillin-streptomycin, and 10 mM HEPES. Store at 4 ºC. Warm to 37 ºC before use.
4. NRVM infection media: M199 media (Invitrogen, Grand Island, NY, USA) supplemented with 2 % FBS (see Note 2), 12 μM l-glutamine, 0.02 μg/mL glucose, 0.05 μg/mL penicillin-streptomycin, and 10 mM HEPES. Store at 4 ºC. Warm to 37 ºC before use.
5.
Fibronectin (BD Biosciences, San Jose, CA, USA): Prepare a stock solution (5 mg/mL) by adding 1 mL distilled water to the vial, aliquot, and store at −20 ºC. For coating cell culture dishes, dilute stock solution in PBS for a final working concentration of 50 μg/mL. Unused fibronectin can be stored at 4 ºC for up to 1 week.
6. Glass-bottomed dishes (14 or 20 mm) (In Vitro Scientific, Sunnyvale, CA, USA). 
7.
Patterned Transgene Expression
1. Sylgard ® 184 Silicone Elastomer Kit (Fisher Scientific, Pittsburgh, PA, USA).
Optogenetic Actuation and Feedback
1.
Quest Rhod-4, AM (AAT Bioquest, Sunnyvale, CA, USA): Prepare a stock solution of 0.5 mM which can be stored at −20 ºC until experimental use. The solvent contains 20 % Pluronic (F127) and 80 % dimethyl sulfoxide (DMSO). Dilute to 10 μM in room-temperature Tyrode's solution for cardio-myocyte staining.
Methods
Isolating and Preparing Cells for Adenoviral Infection
Cells specific to this protocol (NRVM) are isolated using a previously published technique [20] . In short, the ventricular apex is excised from 2-to 3-day-old Sprague-Dawley rats and enzymatically digested overnight with trypsin at 4 ºC and then with collage-nase at 37 ºC the following morning. Cardiac fibroblasts are removed from the cell suspension by a two-stage pre-plating procedure. At the end of the isolation procedure, cardiomyocytes are counted and resuspended in NRVM culture media (see Subheading 2 for recipe) to a concentration of 1.125 × 10 6 cells/mL.
Determining the Optimal Multiplicity of Infection
This section describes the viral infection of cardiomyocytes with opsin genes using a suspension approach with proper dosing for maximum efficiency while maintaining cell viability. Carry out all procedures under a Biosafety Level 2 (BSL-2) cabinet unless otherwise specified (see Note 3).
1.
Prepare a cell suspension of NRVM at a concentration of 1.125×10 6 cells/mL in NRVM culture media (containing 10 % FBS, see Subheading 2 for recipe).
2.
Remove adenovirus from storage at −20 ºC and place on ice (see Note 4).
3.
Separate the total volume of cell suspension into three (or more) conicals for multiplicity of infection (MOI) testing (see Note 5) . For this protocol, we will describe MOI testing at 0 (control), 25, and 100.
4.
Calculate the amount of viral particles needed for infection at the specified MOI (see Note 6):
For example, to infect 2.25 × 10 6 cells (2 mL cell suspension at 1.125×10 6 cells/mL) at MOI 25, 56.25 × 10 6 VP are required.
Calculate and measure out the volume of virus needed for infection:
3 All work with adenoviruses should be completed under the NIH guidelines for working with recombinant DNA. Infections are performed under a certified BSL-2 hood, and personal protection equipment (gloves, lab coat) are worn at all times while handling infectious materials. In addition, for decontamination, all pipets, dishes, and conicals are rinsed with 10 % bleach and autoclaved. 4 Adenoviruses should not undergo multiple freeze/thaw cycles as they could negatively affect performance. Ad-ChR2(H134R) is stored at −20 ºC in a 25 % glycerol solution (2× storage solution: 10 mM Tris pH, 100 mL NaCl, 1 mM MgCl 2 , 0.1 % BSA, and 50 % glycerol). 5 The amount of virus needed for efficient infection of cells (i.e., successful, widespread expression of the transgene and low cytotoxicity) will differ depending on the cell type. For NRVMs, MOIs ranging from 25 to 100 were tested. For example, to infect a 2 mL suspension of NRVM (2.25×10 6 total cells), a total viral volume of 62.5 μL is required.
6.
Mix the viral volume (μL) calculated in step 5 with infection media (containing 2 % FBS, see Note 2 and Subheading 2 for recipe), so that the volume of virus and infection media maintain the original cell concentration of 1.125 × 10 6 cells/mL (see Note 7).
7.
Spin down the cells at 720 × g for 4 min.
8.
Aspirate the culture media from the conical taking care not to disrupt the cell pellet, and resuspend the cells in the infection media and viral particle mixture from step 6.
9.
Incubate the conicals at 37 ºC, 5 % CO 2 , for 2 h with agitation every 15-20 min during this time (see Note 8).
10.
11.
Aspirate the infection media from the conical, again taking care not to disrupt the cell pellet, and resuspend the cells in fresh NRVM culture media maintaining the original cell concentration of 1.125×10 6 cells/mL.
12.
Plate the cells in a monolayer at a density of 350-470 k cells/ cm 2 on fibronectincoated (50 μg/mL, see Note 9) glass-bottomed dishes.
13.
Image transgene expression based on fluorescence of the reporter molecule, in this case eYFP (see Fig. 1 ).
Since optimization of the MOI requires maximizing expression efficiency and minimizing cytotoxic effects, propidium iodide (PI) staining can be used to quantify cell death. PI is a membrane-impermeant DNA stain, excluded from viable cells and commonly used to detect dead cells in a given population.
14. Prepare a 2 μg/mL solution of PI diluted in a Tyrode's solution (see Subheading 2 for recipe). This fluorescent stain is light sensitive, and therefore the application must be completed in the dark.
15. Add 0.5 mL of the 2 μg/mL solution to the glass-bottomed dish containing the cells of interest.
16.
Incubate the cells with PI for 2 min.
17.
Remove the dye solution and wash with fresh Tyrode's solution. 7 In this protocol, infection is completed with the cells in suspension. Provided the cells (like NRVM) tolerate remaining in suspension for a sufficient period of time, infection in this manner allows for better access of the viral particles to the cell surface (membrane) and (in our hands) results in healthier cells post-infection. NRVMs tolerate this protocol well; however it may not be suitable for all cell types. 8 Make sure to shake hard enough to disrupt the pellet of cells and resuspend them sufficiently in order to fully expose them to the virus for infection. 9 Neonatal cells show preference for fibronectin-coated surfaces, whereas adult cells tend to show preference for laminin-coated surfaces [26] .
18. Image cell viability based on the fluorescence of PI using appropriate excitation and emission filter sets (see Fig. 2 ). When PI is bound to nucleic acids, the maximum excitation and emission are 535 nm and 617 nm, respectively.
19.
Based on the overall transgene (ChR2(H134R)-eYFP) expression and cell viability, determine the optimal MOI to be used in future experiments (see Note 10) . For NRVM infected with our custom-designed Ad-ChR2(H134R)-eYFP, the optimal MOI was found to be 25 based on maximal expression and minimal cell death.
Patterned Transgene Expression
The ability to infect NRVM cells in suspension, as opposed to in dish infection after cell plating, allows for patterned optogenetic transgene expression, as described in this section.
To date, we have patterned islands of ChR2(H134R)-eYFP-expressing cells using silicone elastomer stencils, in addition to graded mixtures of infected and uninfected cells mimicking potential in vivo transgene expression patterns.
1.
Thoroughly mix silicone elastomer in the ratio of 10 parts base to 1 part curing agent (total weight of this mixture is 2.2 g).
2.
Pour elastomer mixture into a 60 mm petri dish. Allow the elastomer to spread out and cover the entire bottom of the dish. This volume will yield a 200-250 μm thick layer of silicone.
3.
Bake in an oven at 50-60 ºC for 2 h. Alternatively, the elastomer can be cured at room temperature for 24 h.
4.
In the meantime, coat glass-bottomed dishes with 50 μg/mL of fibronectin (see Note 9) . Cover dishes and leave in the incubator (37 ºC, 5 % CO 2 ) for 1-2 h.
5.
When the elastomer is finished setting, cut out stencils, such as that illustrated in Fig. 3 , in the shape of the desired pattern. The stencil illustrated here will create an island of light-sensitive cardiomyocytes surrounded by normal, uninfected cardiomyocytes or vice versa.
6.
When the glass-bottomed dishes have been coated with fibronectin, remove the solution and carefully place the stencils on the glass-bottomed dish in the desired location (see Note 11). 10 Viral performance may vary between batches. Therefore, a repeat optimization protocol may be necessary. 11 When placing stencils on the fibronectin-coated glass-bottomed dishes, make sure that the dish is dry enough so that the stencil sticks. If not, the cell droplet will spread under the stencil when cells are plated. 12 Ensure that the droplet is of a large enough volume so as not to dry up during this first step of the cell plating procedure. In our experience, a 10 μL droplet is of a sufficient volume and size when placed within a 3 mm diameter stencil.
8. Carefully, remove the stencil and plate uninfected cells at the same plating density in a monolayer on the glass-bottomed dish. 
10.
Image transgene expression based on fluorescence of the reporter molecule (see Fig. 4 for examples of transgene distributions).
Optogenetic Actuation and Feedback
This section describes means of functional testing of the cardiomyocyte samples transduced with the opsin of interest. It demonstrates a combined optical actuation and optical sensing. The macroscopic (large field of view) optical mapping described in this section is done using a custom-developed ultrahigh-resolution system which has been previously described in detail [20] . Other charge-coupled diode (CCD)-, photodiode array (PDA)-, and complementary metal-oxide-semiconductor (CMOS)-based optical mapping systems can also be adapted to this protocol (for review see ref. 25) . Alternatively, the optical sensing can be done with a microscope-integrated photodetector [17] . Here we focus on the choice of optical sensors (i.e., calcium-and voltage-sensitive dyes) and how to trigger optical excitation in NRVM monolayers.
All measurements described here are recorded at room temperature and in the dark so as not to photobleach the fluorescent dyes and/or activate the opsins.
5.
Record electrical activation of the monolayer by pacing with custom-built platinum electrodes connected to a Myopacer Cell Stimulator or equivalent (see Fig. 5b for example of electrical pacing output and Note 15).
6.
Record optical activation of the monolayer using light pulses with a wavelength specific to the opsin integrated into the virus (i.e., 470 nm for ChR2(H134R)) (see Fig. 5b for example of optical pacing output and Notes [16] [17] [18] ). According to a strength-duration curve, the pulse duration can be decreased if higher optical power is used. For example, for our samples, 10-ms optical pulses of 0.01 mW/mm 2 are sufficient to trigger activity in NRVM uniformly expressing ChR2(H134R) (see Note 19) . Patterning stencils: Example schematic of silicone elastomer stencil used to pattern an island of ChR2-expressing NRVMs surrounded by normal, uninfected NRVMs. Not drawn to scale 
